We found that MSH2, MSH6, MLH1, PMS2 and SETD2 independently influencing MSI-H in endometrial carcinoma, colorectal adenocarcinoma, and stomach adenocarcinoma patients. Here, MSH2 is linked to endometrial carcinoma.